EBM Technologies Incorporated (TPEX:8409)
Taiwan · Delayed Price · Currency is TWD 18.10
-0.05 (-0.28%)
Sep 8, 2026, 12:00 PM CST
EBM Technologies Market Cap
EBM Technologies has a market cap or net worth of 580.8 million as of September 4, 2026. Its market cap has decreased by -19.15% in one year.
Market Cap
580.80M
Enterprise Value
520.66M
Revenue
283.73M
Ranking
n/a
PE Ratio
17.86
Stock Price
18.10
ChartMarket Cap Chart
Since April 13, 2010, EBM Technologies's market cap has decreased from 882.35M to 580.80M, a decrease of -34.18%. That is a compound annual growth rate of -2.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 580.80M | -16.55% |
| Dec 31, 2025 | 696.00M | -7.45% |
| Dec 31, 2024 | 752.00M | -6.00% |
| Dec 29, 2023 | 800.00M | 31.93% |
| Dec 30, 2022 | 606.40M | 6.16% |
| Dec 30, 2021 | 571.20M | 11.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 549.12B |
| Lin BioScience | 144.70B |
| Caliway Biopharmaceuticals | 132.52B |
| Pell Bio-Med Technology | 87.93B |
| SynCore Biotechnology Co.,Ltd | 662.86M |
| General Biologicals | 654.83M |
| Carilex Medical | 652.77M |
| Taiwan Advance Bio-Pharmaceutical | 645.30M |